| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $267.27M | - | |
| Dir | 390.7K | $88.26M | - | |
| CEO | 152.2K | $34.38M | - | |
| VP | 72.6K | $16.41M | - | |
| CFO | 59.6K | $13.47M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2019 | Winningham Rick E64 | Director | Sell | 726 | $135.65 | $98,482.19 | -14.1% | |
| Aug 9, 2019 | Sohn Catherine A.55 | Director | Sell | 726 | $135.65 | $98,482.12 | -7.6% | |
| Aug 9, 2019 | Schnee Elmar | Director | Sell | 817 | $135.65 | $110,825.07 | -10.2% | |
| Aug 9, 2019 | Riedel Norbert G63 | Director | Sell | 726 | $135.65 | $98,481.68 | -8.6% | |
| Aug 9, 2019 | O'Keefe Kenneth W63 | Director | Sell | 726 | $135.65 | $98,481.68 | -11.4% | |
| Aug 9, 2019 | McSharry Heather Ann61 | Director | Sell | 787 | $135.65 | $106,755.61 | -8.4% | |
| Aug 9, 2019 | Gray Peter63 | Director | Sell | 787 | $135.65 | $106,756.86 | -7.8% | |
| Aug 9, 2019 | Enright Patrick G74 | Director | Sell | 726 | $135.65 | $98,481.10 | -3.9% | |
| Aug 9, 2019 | Berns Paul L | Director | Sell | 726 | $135.65 | $98,481.10 | -8.4% | |
| Mar 6, 2019 | Treacy Paul | SVP, Technical Operations | Sell | 1,060 | $135.41 | $143,534.60 | -2.5% |